Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Project CBD

OCTOBER 26, 2023

I advise my patients to stop using cannabis for 36 to 48 hours prior to chemotherapy and to start again 36 to 48 hours after their session. Phase 2 is the first study level conducted on patients with the disease for which the drug is intended and determines whether it is safe and effective.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

NOVEMBER 3, 2021

This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

Cannabis Law Report

JUNE 1, 2022

Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients. Our team in Europe is excited to join forces with new colleagues from Pharmadrug GmbH, with their valuable expertise in the German pharmaceutical market.”

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

APRIL 2, 2023

Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has successfully […]

Extraction 52

Extraction Pharmaceutical Patients Business 52

Cannabis Law Report

AUGUST 18, 2021

Seed confirmed on Tuesday that Eurox had successfully launched its own “unique” brand of ‘made in Germany’ full-spectrum medical cannabis extracts, representing a milestone for the company, with products now available for German pharmacies to order. Seed has an 8.85% shareholding in Eurox.

Extraction 105

Extraction Pharmaceutical THC Patients 105

FloridaMarijuana.net

AUGUST 16, 2018

Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. 9-tetrahydrocannabinol (?

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

JULY 21, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 19, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

SEPTEMBER 14, 2021

Join Us in Advancing Cannabis Science to Elevate the Industry , by Pelin Thorogood, Co-founder and Executive Chair of Radicle Science, and Nicole Brown, Chief Innovation Officer of Open Book Extracts. About Open Book Extracts. About Radicle Science. To learn more, please visit www.radiclescience.com and follow their LinkedIn page.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. His team is using novel techniques aimed at untangling the complex interactions between specific plant extracts with cancer cancer cells. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

JULY 2, 2021

CannaVerde Pharma is a vertically integrated medical cannabis company with core operations in Colombia, focused on delivering low-cost, pharmaceutical grade, EU-GMP compliant cannabis-based products to consumers and medical patients in Latin America and Europe. Company Overview. High Margin Revenue Streams. Full Suite of Licenses.

Sleep 105

Sleep Pharmaceutical THC Extraction 105

Project CBD

MARCH 8, 2019

For years, hemp companies have been producing CBD rich extracts and marketing them for animals and humans. Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. In response, veterinarians and others concerned for patient safety promoted a change in state law.

Pets 215

Pets Legalization Hemp Extraction 215

Canna Care Docs

JUNE 22, 2018

An Introductory Lesson on THC Basics For Medical Cannabis Patients. Cannabis, a plant that has proven to be endlessly complex is still under the microscope by researchers, patients, physicians, and society. But many new patients need an introduction on THC basics, learning how it plays a role in a patient’s well-being and healing.

THC 66

THC Patients Blood Pressure Clinical Trials 66

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! In fact, there are some patients who prefer not to smoke because of their health conditions or other reasons. Myth: Cannabis is a cure-all.

Research and Development 116

Research and Development Indica Treatment Conditions 116

Green Relief

MARCH 25, 2018

What makes CBD even more desirable for some patients is that it does not cause the psychoactive effects associated with tetrahydrocannabinol (THC). The study demonstrated that a whole plant extract, containing the entire range of cannabinoids present in raw cannabis, will continue to provide relief for inflammation as the dose is increased.

Extraction 41

Extraction CBD Cannabinoids Strains 41

Cannabis Law Report

APRIL 29, 2022

LONDON, April 29, 2022 –( BUSINESS WIRE )–Curaleaf International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Patients 52

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low. Product Split.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Pharmaceutical 98

Pharmaceutical Research and Development Epilepsy Medicine 98

Cannabis Law Report

AUGUST 9, 2021

The company’s innovative technology enables the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract in a homogeneous, uniform and stable formulation which can be administered in the form of oral capsules, syrups or buccal sprays.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

FloridaMarijuana.net

OCTOBER 5, 2018

In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Phytol is considered a diterpene , present in cannabis extracts, as a breakdown product of chlorophyll and tocopherol.

Terpenes 181

Terpenes Strains Oil Medicine 181

United Patients Group

FEBRUARY 7, 2023

Cannabis is an effective treatment for pain and inflammation Cannabis is a natural alternative to pharmaceutical drugs. The most effective way depends on the patient’s condition and overall health status but generally speaking most people prefer inhalation over other methods because it delivers relief quickly (within minutes).

Cannabinoids 116

Cannabinoids Chronic Pain Terpenes THC 116

Cannabis Law Report

JULY 7, 2021

Part of larger supply agreement with BOL Pharma to serve rapidly growing number of medical cannabis patients in Israel. We look forward to strengthening our relationship with BOL as we continue to service the growing patient demand for high quality medical cannabis in Israel.”. – Ends – About Curaleaf International.

Research and Development 98

Research and Development Cultivation Extraction Patients 98

MMJ Recs

JULY 11, 2024

Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. Another option available is the use of medical marijuana to address insomnia in patients.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Veriheal

MARCH 7, 2023

During the inauguration, Georgiadis noted that Greek patients stand to benefit from using plant-produced medicines, despite cannabis “having a difficult history due to its nature as a narcotic.” M edicinal-grade cannabis will be cultivated inside a 25,000-square-foot extraction and processing facility as part of the Greek Kaya Project.

Marijuana 98

Marijuana Pharmaceutical Medicine Cultivation 98

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. Here’s the press release. All intellectual property from the trials will be owned by MGC, which is funding the research.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

SpeedWeed

SEPTEMBER 9, 2021

In fact, the pharmaceutical infrastructure that faces medical cannabis companies is far from either clear cut or easy to navigate. for example), pharmaceutical drugs may not be advertised directly to potential consumers (also known as patients). The Future of Generic Extracts. Here is why. Unlike the U.S.

Legalization 52

Legalization Pharmaceutical Patients Extraction 52

Cannabis Law Report

MARCH 25, 2020

Panaxia Israel has just imported from the US hemp extracts from which it will manufacture CBD-rich cannabis products. Essence extraction was conducted in a facility jointly operated by Panaxia and Ultra Health located in New Mexico , US. About Panaxia Israel.

Oil 45

Oil Pharmaceutical Epilepsy Extraction 45

MedicalJane

MAY 21, 2020

The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. Westlund, Department of Anesthesiology.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

JUNE 28, 2021

He has previously been involved in advocating medical cannabis for the benefit of patients through his work on a number of medical and policy bodies. ABOUT KANABO GROUP PLC: Kanabo is an industry leader in product development and commercialisation of both cannabis-derived products for medical patients and THC-free products for CBD consumers.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Veriheal

JANUARY 25, 2022

Patients have expressed their disappointment with quality and pricing, citing the black market or other legal states as much better alternatives. The statement confirms that the farm bill did not legalize products made with CBD extracted from hemp. A theory towards a solution would be for all hemp extracts to be approved by the FDA.

Hemp 98

Hemp Business CBD Seed-To-Sale 98

United Patients Group

FEBRUARY 2, 2023

There are also other parts of the plant with different uses such as seeds which can be eaten like nuts; stems/leaves which can be cooked into tea; resins/oils which can be ingested thru various methods including capsules, tinctures & edibles; and finally extracts which come from isolating specific compounds found within whole plants.

Blood Pressure 105

Blood Pressure Sleep Chronic Pain Digestion 105